Osteoradionecrosis of the mandible

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 4, 2005, Pages 217-221

  Teng, Marita S ^a   Futran, Neal D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperbaric oxygen; Jaw; Mandible; Osteoradionecrosis; Radiation necrosis

Indexed keywords

BONE NECROSIS; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; INCIDENCE; JAW DISEASE; MANDIBLE; PATHOGENESIS; PRIORITY JOURNAL; RADIATION NECROSIS; REVIEW; RISK FACTOR;

DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MANDIBLE; MANDIBULAR DISEASES; OSTEORADIONECROSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS;

EID: 22344437937     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000170527.59017.ff     Document Type: Review

References (40)

1. Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 2000; 58:1088-1093.
2. Marx R. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 1983; 41:351-357.
3. Schwartz HC, Kagan RK. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol 2002; 25:168-171.
4. Ewing J. Radiation osteitis. Acta Radiol 1926; 6:399-412.
5. Store G, Boysen M. Mandibular osteoradionecrosis: clinical behavior and diagnostic aspects. Clin Otolaryngol 2000; 25:378-384.
6. Reuther T, Schuster T, Mende U, Kubler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumor patients: a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003; 32:289-295.
7. Epstein J, Wong F, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 1987; 45:104-111.
8. Glanzmann C, Gratz KW. Radionecrosis of the mandible: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995; 36:94-100.
9. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002; 28:65-74.
10. Mendenhall WM. Mandibular osteoradionecrosis. J Clin Oncol 2004; 22:4867-4868. This brief review of this topic also summarizes some data from almost 1500 patients at the University of Florida.
11. Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol 2004; 180:233-240. This paper presents a decrease in the incidence of mandibular ORN in the 1990's vs. the 1980's, using hyperfractionated and moderately accelerated radiation, as well as 3D conformal techniques.
12. Kluth EV, Jain PR, Stuchell RN, et al. A study of factors contributing to the development of osteoradionecrosis of the jaws. J Prosthet Dent 1988; 59:194.
13. Marx RE. Radiation injury to tissue. In: Kindwall EP, editor. Hyperbaric medicine practice. Flagstaff, AZ: Best Publishing Co.; 1994. pp.448-503.
14. Notani K, Yamazaki Y, Kitada H, et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 2003; 25:181-186.
15. Fujita M, Hirokawa Y, Kashiwado K, et al. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue, Int J Radiat Oncol Biol Phys 1996; 34:333-339.
16. Oh HK, Chambers MS, Garden AS, et al. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg 2004; 62:139-144. Although widely believed that postirradiation tooth extraction produces a higher rate of ORN, this study fails to demonstrate a difference between preirradiation extraction and retention of third molars.
17. Beumer J, Harrison R, Sanders B, et al. Osteoradionecrosis: predisposing factors and outcomes of therapy. Head Neck Surg 1984; 6:819.
18. Murray CG, Herson J, Daly TE, et al. Radiation necrosis of the mandible: a 10-year study. Part II. Dental factors; onset, duration, and management of necrosis. Int J Radiat Oncol Biol Phys 1980; 6:549.
19. Assael LA. New foundations in understanding osteonecrosis of the jaws. Oral Maxillofac Surg 2004; 62:125-126. A brief review of recent literature on this topic, emphasizing the finding that radiogenic alterations occur in osteoclasts before vascular changes are apparent.
20. Al-Nawas B, Duschner H, Grotz KA. Early cellular alterations in bone after radiation therapy and its relation to osteoradionecrosis [letter]. J Oral Maxillofac Surg 2004; 62:1045. Short letter corroborating evidence from the previous article.
21. Ruggiero SL, Mehrontra B, Rosenberg TJ, Engroff SL. Osteonecrosis of jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62:527-534. This is an important paper documenting a relatively new observation that bisphosphonates are associated with mandibular ORN. It explores the possible etiologies of this condition, bringing to bear recent theories that inhibition of osteoclast function is a critical step in the development of ORN.
22. Marx RE. Pamidronate- and zolendronate-induced avascular necrosis of the jaws: a growing epidemic [letter], J Oral Maxillofac Surg 2003; 61:1115.
23. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003; 61:1104.
24. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004; 73:119-131. A comprehensive review of what is known about the cellular basis for development of ORN through a fibroatrophic process, this article also explains the groundwork for using free radical scavengers for treatment.
25. Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol 2004; 72:1-13. Reviews the use of HBO in radiation-induced lesions (head/neck and otherwise).
26. Chavez JA, Adkinson CD. Adjunctive hyperbaric oxygen in irradiated patients requiring dental extractions: outcomes and complications. J Oral Maxillofac Surg 2001; 59:518-522.
27. Marx RE, Johnson RP, Kline SN. Prevention of osteoradioneorosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 1985; 111:49-54.
28. Bui QC, Lieber M, Withers HR, et al. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 2004; 60:871-878. A retrospective study demonstrating that HBO was beneficial for late radiation-induced side effects, particularly for head and neck sites. The authors found ORN to be especially responsive to HBO therapy.
29. Clayman L. Clinical controversies in oral and maxillofacial surgery: part two. Management of dental extractions in irradiated jaws: a protocol without hyperbaric oxygen therapy. J Oral Maxillofac Surg 1997; 55:275-281.
30. Katsikeris N, Young ER. Postirradiation dental extraction without hyperbaric oxygen. Oral Surg Oral Med Oral Pathol 1992; 74:155-157.
31. Sulaiman F, Huryn JM, Slotolow IM. Dental extractions in the irradiated head and neck patient: a retrospective analysis of the Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. J Oral Maxillofac Surg 2003; 61:1123-1131.
32. Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 2004; 22:4893-4900. A very unique study demonstrating the lack of benefit of HBO in advanced ORN. Surprisingly, it was terminated prior to the planned schedule due to lower recovery rates in the HBO arm than the placebo arm.
33. Rudolph R, Tripuraneni P, Koziol JA, et al. Normal transcutaneous oxygen pressure in skin after radiation therapy for cancer. Cancer 1994; 74:3063-3070.
34. Maier A, Gaggl A, Kiemen H, et al. Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation. Br J Oral Maxillofac Surg 2000; 38:173-176.
35. Gal TJ, Yueh B, Futran ND. Influence of prior hyperbaric oxygen therapy in complications following microvascular reconstruction for advanced osteoradionecrosis. Arch Otolaryngol Head Neck Surg 2003; 129:72-76.
36. Futran ND, Trotti A, Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope 1997; 107:391-395.
37. Delanian S, Baillet F, Huart J, et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: a clinical trial. Radiother Oncol 1994; 32:12-20.
38. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 1999; 17:3283-3290.
39. Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 2005; 27:114-123. This paper presents successful phase II results of a trial using the anti-TNF, erythrocyte flexibility-inducing drug pentoxifylline, the antioxidant tocopherol, and interestingly, the bisphosphonate clodronate, in treatment of ORN.
40. Delanian S, Lefaix JL. Complete healing of severe osteoradionecrosis by treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 2002; 75:467-469.